Reliable Audit Solutions to Ensure Global Compliance and Safeguard Your Supply Chain
We are reputable provider of 17 years of experience in GMP audits to ensure products meet industry standards and quality standards. Our experienced team conducts GMP audits globally, assessing a pharma company’s control over processes, facilities, and QMS, including API, intermediates, raw materials, warehouses, and packaging facilities. Trust Zenovel for reliable GMP audits that help maintain excellence in pharmaceutical manufacturing.
We conducts third-party GMP audits using experienced auditors to assess a supplier’s compliance with regulatory standards, including detailed documentation review, on-site inspections, staff interviews, and comprehensive reporting to ensure adherence to Good Manufacturing Practice guidelines.
We understand the demands and constraints placed on pharmaceutical firms, as well as the pressure their suppliers face from audits. This inspired us to develop a strategy that benefits all stakeholders while offering a premium audit service.
Our framework provides elite audit services tailored to the demands of pharmaceutical firms’ effectively addressing challenges in supplier auditing. We prioritize adherence to standards, regulations, and impartiality, avoiding conflicts of interest and supplier-customer interactions.
We streamline auditing process by identifying top-tier auditing firms and auditors, coordinating all stakeholders to align audit schedule with auditor and sponsor timelines.
Upon contract agreement, we promptly initiate audit planning, scheduling audit days based on the auditor and sponsors deadlines. After scheduling, the company seeks competent auditors and qualified teams to effectively handle and execute the audit.
Utilize our complete audit life cycle management services to streamline your supplier audit, covering planning, execution, reporting, and CAPA follow up, allowing you to efficiently manage and conclude audits for your suppliers. From here we take care of audit from beginning to the end.
We conducts third-party GMP audits using experienced auditors to assess a supplier’s compliance with regulatory standards, including detailed documentation review, on-site inspections, staff interviews, and comprehensive reporting to ensure adherence to Good Manufacturing Practice guidelines.
We provide Joint Audit Services, a collaborative auditing method where multiple parties collaborate. This approach ensures comprehensive assessments, optimizes efficiency, reduces duplication, and enhances transparency. It leads to improved compliance and quality. Trust Zenovel for expertly managed joint audit services, fostering cooperation and driving excellence in regulatory compliance.
We are qualified to audit a wide range of international manufacturers of pharmaceutical drugs and to all applicable regional and global compliance requirements.
Auditors maintain a high level of impartiality in their evaluations, assessing sponsors’ specific requirements and communicating them to the auditors using unbiased standards
The audit sponsors, auditors, and sponsors are all subjected to strict confidentiality conditions, including through NDAs or CDAs, to ensure the integrity of all information.
The EMA guidelines mandate that auditors and sponsors must have no commercial connections, which auditors thoroughly examine during the audit process to ensure regulatory compliance.
Each sponsor receives a detailed report tailored to their interests and specific updates based on their criteria.
We offer global audit services with native auditors, ensuring comprehensive coverage and adherence to international standards in any country.
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is the
Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5
Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
Navigating the world of pharmaceuticals, medical devices, and biotechnology is never straightforward. With the diversity of regulatory compliance governs the Code of Federal Regulations (CFR) – a regulatory path that shapes companies’ efforts and implements how companies long for their products to be developed, manufactured, and marketed. For companies trying
The race to deliver life-saving therapies to patients is increasingly faster and more complex. Pharmaceutical and biotech companies are faced with a dizzying list of challenges — global clinical trials, continuously changing regulations, multiple complicated therapeutic areas, and pressure to innovate. This is where Contract Research Organizations (CRO) come in: